Adverse drug reactions - No farewell to harms

British Journal of Clinical Pharmacology

Volumn 63, Issue 2, 2007, Pages 131-135

  Aronson, Jeffrey K ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; CONTRACEPTIVE AGENT; GLYCERYL TRINITRATE; ISOTRETINOIN; LAXATIVE; NIFEDIPINE; QUINIDINE;

CHEMICAL REACTION; CLUBBING FINGERS; CONCENTRATION RESPONSE; DOSE RESPONSE; DRUG CLASSIFICATION; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG SAFETY; DRUG SENSITIVITY; DRUG SURVEILLANCE PROGRAM; DRUG TOLERANCE; DRUG WITHDRAWAL; DYSGEUSIA; EDITORIAL; HEADACHE; HUMAN; HYPERTENSION; MASS ACTION; POLYPHARMACY; POSTMARKETING SURVEILLANCE; PREGNANCY; PRIORITY JOURNAL; QT PROLONGATION; REACTION TIME; SIDE EFFECT;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; DRUG THERAPY; FEMALE; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MALE; MIDDLE AGED; PREGNANCY;

EID: 33846073027     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2006.02860.x     Document Type: Editorial

References (32)

1. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ 2004; 329: 15-9.
2. Howard RL, Avery AJ, Slavenburg S, Royal S, Pipe G, Lucassen P, Pirmohamed M. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2007; 63: 136-47.
3. Aronson JK. Risk perception in drug therapy. Br J Clin Pharmacol 2006; 62: 135-7.
4. Levine RR. Factors modifying the effects of drugs in individuals. In: Pharmacology. Drug actions and reactions. Boston: Little, Brown and Co, 1973: 261-91.
5. Wayne EJ. Problems of toxicity in clinical medicine. In: Walpole AL, Spinks A, editors. The Evaluation of Drug Toxicity. London: J & A Churchill Ltd, 1958: 1-11.
6. Aronson JK, Ferner RE. Joining the DoTS: new approach to classifying adverse drug reactions. BMJ 2003; 327: 1222-5.
7. Law MR, Morris JK, Wald NJ. Calcium channel blockers and headache. Br J Clin Pharmacol 2007; 63: 157-8.
8. De Bruin ML, Langendijk PNJ, Koopmans RP, Wilde AAM, Leufkens HGM, Hoes AW. In-hospital cardiac arrest is associated with use of non-antiarrhythmic QTc-prolonging drugs. Br J Clin Pharmacol 2007; 63: 216-23.
9. Atthobari J, Gansevoort RT, Visser ST, de Jong PE, De Jong-van den Berg LTW; On behalf of the PREVEND Study Group. The impact of hormonal contraceptives on blood pressure, urinary albumin excretion and glomerular filtration rate. Br J Clin Pharmacol 2007; 63: 224-31.
10. Currie GP, Niruban A, Dempsey OJ. A rare cause of finger clubbing in a life-long nonsmoker. Br J Clin Pharmacol 2007; 63: 252.
11. Pines A, Olchovsky D, Bregman J, Kaplinsky N, Frankl O. Finger clubbing associated with laxative abuse. South Med J 1983; 76: 1071-2.
12. FitzGerald O, Redmond J. Anthraquinone-induced clubbing associated with laxative abuse. Ir J Med Sci 1983; 152: 246-7.
13. Sadasivam B, Jhaj R. Dysgeusia with amlodipine - a case report. Br J Clin Pharmacol 2007; 63: 253.
14. Berman JL. Dysosmia, dysgeusia, and diltiazem. Ann Intern Med 1985; 102: 717.
15. Heckmann SM, Hujoel P, Habiger S, Friess W, Wichmann M, Heckmann JG, Hummel T. Zinc gluconate in the treatment of dysgeusia - a randomized clinical trial. J Dent Res 2005; 84: 35-8 [erratum 382].
16. LaRocca D, Lehmann DF, Perl A, Ozawa T, Holohan PD. The combination of nuclear and mitochondrial mutations as a risk factor for idiosyncratic toxicity. Br J Clin Pharmacol 2007; 63: 249-51.
17. Shin J-G, Kang W-K, Shon J-H, Arefayene M, Yoon Y-R, Kim K-A, Kim D-I, Kim D-S, Cho K-H, Woosley RL, Flockhart DA. Possible interethnic differences in quinidine-induced QT prolongation between healthy Caucasian and Korean subjects. Br J Clin Pharmacol 2007; 63: 206-15.
18. Zhang M, Holman CDJ, Preen DB, Brameld K. Repeat adverse drug reactions causing hospitalization in older Australians: a population-based longitudinal study 1980-2003. Br J Clin Pharmacol 2007; 63: 163-70.
19. George J, Munro K, McCaig D, Stewart D. Risk factors for medication misadventure among residents in sheltered housing complexes. Br J Clin Pharmacol 2007; 63: 171-6.
20. Laroche M-L, Charmes J-P, Nouaille Y, Picard N, Merle L. Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol 2007; 63: 177-86.
21. van der Velde N, Stricker BHCh, Pols HAP, Van Der Cammen TJM. Risk of falls after withdrawal of fall-risk-increasing drugs: a prospective cohort study. Br J Clin Pharmacol 2007; 63: 232-7.
22. French DD, Campbell R, Spehar A, Rubenstein LZ, Branch LG, Cunningham F. National outpatient medication profiling: medications associated with outpatient fractures in community-dwelling elderly veterans. Br J Clin Pharmacol 2007; 63: 238-44.
23. Bérard A, Azoulay L, Koren G, Blais L, Perreault S, Oraichi D. Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective. Br J Clin Pharmacol 2007; 63: 196-205.
24. Viktil KK, Blix HS, Moger TA, Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007; 63: 187-95.
25. Aronson JK. Polypharmacy, appropriate and inappropriate. Br J Gen Pract 2006; 56: 484-5.
26. Loke YK, Derry S. Reporting of adverse drug reactions in randomised controlled trials - a systematic survey. BMC Clin Pharmacol 2001; 1: 3.
27. Derry S, Kong Loke Y, Aronson JK. Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials. BMC Med Res Methodol 2001; 1: 7.
28. van Luijn JCF, Gribnau FWJ, Leufkens HGM. Availability of comparative trials for the assessment of new medicines in the European Union at the moment of market authorization. Br J Clin Pharmacol 2007; 63: 159-62.
29. Aronson JK. Metameta-analysis. Br J Clin Pharmacol 2005; 60: 117-9.
30. Aronson JK, Hauben M. Anecdotes that provide definitive evidence. BMJ 2006; 333: 1267-9.
31. Loke YK, Price D, Derry S, Aronson JK. Case reports of Claude Louis Berthollet (1748-1822) suspected adverse drug reactions - systematic literature survey of follow-up. BMJ 2006; 332: 335-9.
32. Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol 2007; 63: 148-56.